Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLOBUS MEDICAL INCGMED · Entity 3496 | Senior Vice President, CFO | January 21, 2026 | January 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLOBUS MEDICAL INC
Report date January 21, 2026 · Filed January 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $94.15 · Expires 2036-01-21 | Direct | 30,000 |
Reported balance
After 2026-01-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-21 · Grant · Acquired 30,000 · Balance 30,000 F1: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, and then 1/48 of the options vesting each month thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, and then 1/48 of the options vesting each month thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 21, 2026 Filed Jan 23, 2026 17:05 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 30,000 | $0.00 Strike: $94.15 | $0.00 |
DisclosureSEC source: 0001193125-26-021249 · ownership.xml · derivative · entry 1 Kline Kyle · CIK 0002080625 · Senior Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Class A Common Stock · 30,000 shares Expires 2036-01-21 F1 · derivative.exercise_date: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, and then 1/48 of the options vesting each month thereafter. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 17:40 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 3,594 | $0.00 Strike: $51.87 | $0.00 |
DisclosureSEC source: 0001193125-26-010699 · ownership.xml · derivative · entry 3 Kline Kyle · CIK 0002080625 · Senior Vice President, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,906 Underlying: Class A Common Stock · 3,594 shares Expires 2034-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on March 14, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 17:40 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 3,594 | $101.10 | $363,353.40 |
DisclosureSEC source: 0001193125-26-010699 · ownership.xml · nonDerivative · entry 2 Kline Kyle · CIK 0002080625 · Senior Vice President, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated August 25, 2025 executed by the reporting person. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 17:40 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 3,594 | $51.87 | $186,420.78 |
DisclosureSEC source: 0001193125-26-010699 · ownership.xml · nonDerivative · entry 1 Kline Kyle · CIK 0002080625 · Senior Vice President, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 20:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 5,000 | $0.00 Strike: $63.68 | $0.00 |
DisclosureSEC source: 0001193125-25-307215 · ownership.xml · derivative · entry 9 Kline Kyle · CIK 0002080625 · Senior Vice President, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,000 shares Expires 2032-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 20:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 5,000 | $0.00 Strike: $64.44 | $0.00 |
DisclosureSEC source: 0001193125-25-307215 · ownership.xml · derivative · entry 8 Kline Kyle · CIK 0002080625 · Senior Vice President, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,000 shares Expires 2031-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on January 25, 2021 and are fully vested. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 20:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 5,000 | $0.00 Strike: $56.43 | $0.00 |
DisclosureSEC source: 0001193125-25-307215 · ownership.xml · derivative · entry 7 Kline Kyle · CIK 0002080625 · Senior Vice President, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 5,000 shares Expires 2034-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on February 27, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 20:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 3,646 | $0.00 Strike: $53.14 | $0.00 |
DisclosureSEC source: 0001193125-25-307215 · ownership.xml · derivative · entry 6 Kline Kyle · CIK 0002080625 · Senior Vice President, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,354 Underlying: Class A Common Stock · 3,646 shares Expires 2033-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on March 24, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 20:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 18,542 | $90.00 | $1,668,780.00 |
DisclosureSEC source: 0001193125-25-307215 · ownership.xml · nonDerivative · entry 5 Kline Kyle · CIK 0002080625 · Senior Vice President, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated August 25, 2025 executed by the reporting person. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 20:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 4,896 | $63.68 | $311,777.28 |
DisclosureSEC source: 0001193125-25-307215 · ownership.xml · nonDerivative · entry 4 Kline Kyle · CIK 0002080625 · Senior Vice President, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 20:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 5,000 | $64.44 | $322,200.00 |
DisclosureSEC source: 0001193125-25-307215 · ownership.xml · nonDerivative · entry 3 Kline Kyle · CIK 0002080625 · Senior Vice President, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 20:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 5,000 | $56.43 | $282,150.00 |
DisclosureSEC source: 0001193125-25-307215 · ownership.xml · nonDerivative · entry 2 Kline Kyle · CIK 0002080625 · Senior Vice President, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 20:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 3,646 | $53.14 | $193,748.44 |
DisclosureSEC source: 0001193125-25-307215 · ownership.xml · nonDerivative · entry 1 Kline Kyle · CIK 0002080625 · Senior Vice President, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2025 Filed Jan 13, 2026 17:40 UTC Amendment | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 4,896 | $0.00 Strike: $63.68 | $0.00 |
DisclosureSEC source: 0001193125-26-011926 · ownership.xml · derivative · entry 1 Kline Kyle · CIK 0002080625 · Senior Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104 Underlying: Class A Common Stock · 4,896 shares Expires 2032-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 3, 2025, the reporting person filed a Form 4 which inadvertently reported in Table II that 5,000 options were exercised prior to the sale of the underlying 4,896 shares of the issuer's Class A Common Stock that was reported in Table I. As correctly reported in this amendment, the reporting person exercised 4,896 options prior to the sale of the underlying 4,896 shares of the issuer's Class A Common Stock. F2 · derivative.exercise_date: These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| July 18, 2025 Filed Aug 27, 2025 18:10 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 20,909 | $0.00 Strike: $56.34 | $0.00 |
DisclosureSEC source: 0000950170-25-111761 · ownership.xml · derivative · entry 1 Kline Kyle · CIK 0002080625 · Senior Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,909 Underlying: Class A Common Stock · 20,909 shares Expires 2035-07-18 F1 · derivative.exercise_date: These options were granted on July 18, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on July 18, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.